PRA Health Sciences entered into a new facility comprised of a $625 million term loan facility and revolving credit facility in a maximum amount of up to $125 million, in each case with a maturity date of December 6, 2021.

According to a related 8-K filing, Wells Fargo served as administrative agent, collateral agent, letter of credit issuer and swing-line lender for a group of lenders.

PRA refinanced the credit agreement dated September 23, 2013 with UBS AG, Stamford Branch, as agent.